MarineMax, Inc.
NYSE:HZOSpecialty Retail
+$1.29 today
- Market cap
- $1.17B
- Beta
- 1.60
- P/E (TTM)
- -11.9
- EPS (TTM)
- -$2.89
Volume 0.93M
Average 0.34M
HZO EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
MarineMax, Inc.NYSE: HZO
EBITDA · Q2 FY2026 · quarter ended Mar 2026
EBITDA declines year over year
Q2 FY2026 EBITDA of $23.55M fell 32.7% year over year, ahead of the -34.5% change in trailing-twelve-month EBITDA. Sequentially, it rose 34.6% from the prior quarter. Over 3 fiscal years it compounded at -34.0% a year.
Context
- EBITDA amounted to 3.6% of revenue in FY2025, down 3.4 pp from a year earlier.
- EBITDA increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 6 analysts of $127.38M (+52.8%) for the fiscal year ending Sep 2026, a step up from the -50.9% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $23.55M+34.6% QoQ
- Last fiscal yearSep 2025
- $83.34M-50.9% YoY
- LTMMar 2026
- $107.88M-34.5% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -32.7% | +22.9% | +55.6 pp |
| 1 year | -50.9% | +52.8% | +103.7 pp |
| 3-year CAGR | -34.0% | +31.5% | +65.5 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 83.34M USD
- Year-over-year change
- -50.9%
- 4-year CAGR
- -22.0%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 83.34M | -50.9% |
| FY2024 | 2024-09-30 | 169.68M | -30.5% |
| FY2023 | 2023-09-30 | 244.21M | -15.9% |
| FY2022 | 2022-09-30 | 290.42M | +29.0% |
| FY2021 | 2021-09-30 | 225.07M | — |
EBITDA vs competitors
How HZO compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -34.5% is the lowest of 11, against a peer median of +46.6%.
- EBITDA amounts to 4.8% of revenue for HZO, versus a peer median of 4.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | MX$2.84B MXN | +39.9% | +6.1% | 19.9% | |
| LTM Mar 2026 | $268.54M USD | +10.6% | -2.0% | 3.5% | |
| LTM Mar 2026 | $107.88M USD | -34.5% | -34.0% | 4.8% | |
| LTM May 2026 | $87.75M USD | -26.6% | -21.6% | 7.8% | |
| LTM May 2026 | $61.92M USD | -21.9% | +5.4% | 4.7% | |
| LTM Mar 2026 | $53.99M USD | -25.7% | -14.1% | 33.1% | |
| LTM Mar 2026 | $42.49M USD | +53.3% | -36.7% | 5.1% | |
| LTM Mar 2026 | CN¥19.92M CNY | +104.1% | — | 0.4% | |
| LTM May 2026 | $9.45M USD | +122.7% | — | 0.7% | |
| LTM Mar 2026 | -$43.97M USD | +53.6% | — | 21.6% | |
ZKHZKH Group Limited | LTM Mar 2026 | -CN¥60.75M CNY | +70.8% | — | 0.7% |
| Peer median (excluding HZO) | — | +46.6% | -8.0% | 4.9% | |
Competitors are the stored peer set for HZO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Revenue | 2.06B | 2.31B | 2.39B | 2.43B | 2.31B |
| Cost of Revenue | 1.4B | 1.5B | 1.56B | 1.63B | 1.56B |
| Gross Profit | 659.43M | 805.75M | 835.33M | 801.2M | 750.23M |
| Gross Margin | 32.0% | 34.9% | 34.9% | 33.0% | 32.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 449.97M | 540.55M | 632.16M | 676M | 647.16M |
| Operating Expenses | 449.97M | 540.55M | 634.53M | 672.97M | 647.16M |
| Depreciation & Amortization | 15.61M | 19.42M | 41.03M | 44.49M | 49.32M |
| EBITDA | 225.07M | 290.42M | 244.21M | 169.68M | 83.34M |
| EBITDA Margin | 10.9% | 12.6% | 10.2% | 7.0% | 3.6% |
| Operating Income | 209.46M | 265.2M | 200.8M | 128.23M | 103.07M |
| Operating Margin | 10.2% | 11.5% | 8.4% | 5.3% | 4.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 3.67M | 3.28M | 53.37M | 73.9M | 71.16M |
| Other Income / Expenses | (3.67M) | (3.28M) | (53.37M) | (73.9M) | (140.21M) |
| Income Before Tax | 205.79M | 261.92M | 147.44M | 54.33M | (37.14M) |
| Pre-Tax Margin | 10.0% | 11.3% | 6.2% | 2.2% | -1.6% |
| Income Tax Expense | 50.82M | 63.93M | 37.96M | 15.59M | (6.38M) |
| Net Income | 154.98M | 197.99M | 109.28M | 38.07M | (31.63M) |
| Net Margin | 7.5% | 8.6% | 4.6% | 1.6% | -1.4% |
| EPS (Basic) | 7.04 | 9.12 | 5.00 | 1.71 | (1.43) |
| EPS (Diluted) | 6.78 | 8.84 | 4.87 | 1.65 | (1.43) |
| Weighted Avg Shares | 22.01M | 21.71M | 21.85M | 22.27M | 22.05M |
| Weighted Avg Shares (Diluted) | 22.86M | 22.4M | 22.43M | 23.01M | 22.05M |
MarineMax, Inc.
NYSE:HZO
Intrinsic Alpha fair value
Locked
Current Price
$52.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.